These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18373055)

  • 1. Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study.
    Huot L; Couris CM; Tainturier V; Jaglal S; Colin C; Schott AM
    Osteoporos Int; 2008 Jul; 19(7):1047-54. PubMed ID: 18373055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study.
    Reymondier A; Caillet P; Abbas-Chorfa F; Ambrosi V; Jaglal SB; Chapurlat R; Schott AM
    Osteoporos Int; 2013 Feb; 24(2):559-66. PubMed ID: 22588183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Prescribing Menopausal Hormone Therapy and Bisphosphonates in Australia and Manitoba, Canada and Adherence to Recommendations.
    Salagame U; Kliewer EV; Demers A; Banks E; Velentzis LS; Goldsbury D; Egger S; Leslie WD; Canfell K
    J Womens Health (Larchmt); 2020 Feb; 29(2):177-186. PubMed ID: 31895627
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.
    Foster SA; Foley KA; Meadows ES; Johnston JA; Wang S; Pohl GM; Long SR
    BMC Womens Health; 2008 Dec; 8():24. PubMed ID: 19105828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prescribing pattern of bisphosphonate and raloxifene in Korean women with osteoporosis: from a national health insurance claims database.
    Kim J; Shin JY; Lee J; Song HJ; Choi NK; Park BJ
    PLoS One; 2015; 10(6):e0127970. PubMed ID: 26030300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
    Watson J; Wise L; Green J
    Eur J Clin Pharmacol; 2007 Sep; 63(9):843-9. PubMed ID: 17598097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in postmenopausal osteoporosis treatment in France during the period 2007-2016: A nationwide claims database analysis.
    Cortet B; Schott AM; Désaméricq G; Chauny JV; Samama P; Emery C; Fagnani F
    Bone; 2022 Jan; 154():116255. PubMed ID: 34763115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage.
    Cadarette SM; Carney G; Baek D; Gunraj N; Paterson JM; Dormuth CR
    Osteoporos Int; 2012 Apr; 23(4):1475-80. PubMed ID: 21901476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
    Udell JA; Fischer MA; Brookhart MA; Solomon DH; Choudhry NK
    J Bone Miner Res; 2006 May; 21(5):765-71. PubMed ID: 16734392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive analysis of concomitant prescription medication patterns from 1999 to 2004 among US women receiving daily or weekly oral bisphosphonate therapy.
    Gold DT; Bonnick SL; Amonkar MM; Kamel HK; Agarwal S; Zaidi M
    Gend Med; 2008 Dec; 5(4):374-84. PubMed ID: 19108810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
    Naik-Panvelkar P; Norman S; Elgebaly Z; Elliott J; Pollack A; Thistlethwaite J; Weston C; Seibel MJ
    BMC Fam Pract; 2020 Feb; 21(1):32. PubMed ID: 32050909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study.
    Clemens KK; Jeyakumar N; Ouédraogo AM; Thain J; Khan T
    Arch Osteoporos; 2020 Aug; 15(1):133. PubMed ID: 32816151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
    Fujiwara S; Miyauchi A; Hamaya E; Nicholls RJ; Weston A; Baidya S; Pinto L; Barron R; Takada J
    Arch Osteoporos; 2018 Mar; 13(1):34. PubMed ID: 29564555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERT, HRT, raloxifine, calcitonin, or bisphosphonates for osteoporosis.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(2):178-81. PubMed ID: 14613350
    [No Abstract]   [Full Text] [Related]  

  • 15. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
    Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.
    Gu T; Eisenberg Lawrence DF; Stephenson JJ; Yu J
    Clin Interv Aging; 2016; 11():1-8. PubMed ID: 26929609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence.
    Roerholt C; Eiken P; Abrahamsen B
    Osteoporos Int; 2009 Feb; 20(2):299-307. PubMed ID: 18551241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E; Wutoh AK; Xue Z; Hillman JJ; Zuckerman IH
    J Womens Health (Larchmt); 2006 Mar; 15(2):155-61. PubMed ID: 16536679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.